CIK 0000070487
- Accelerated filer
NRC HEALTH
Sign in to watch- Ticker
- NRC
- Exchange
- Nasdaq
- Industry
- Services-Commercial Physical & Biological Research
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 470634000
- Phone
- +1 402-475-2525
- Business address
- 1245 Q STREET, LINCOLN, NE, 68508
- Former names
- NATIONAL RESEARCH CORP
- 4 Open-market sale CEO sold 26,627 shares at an average $14.64 ($389,776)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 12,065 shares at $31.60 ($381,208)
- 4 Open-market sale CEO sold 857 shares at $32.50 ($27,853)
- 4 Open-market sale CEO sold 19,650 shares at an average $22.67 ($445,384)
- 4 Open-market sale CEO sold 3,794 shares at an average $14.00 ($53,118)
- 4 Open-market sale CEO sold 61,648 shares at an average $14.00 ($863,093)
- 4 Open-market sale CEO sold 4,770 shares at an average $14.67 ($69,983)
- 4 Open-market sale CEO sold 764 shares at an average $34.05 ($26,017)
- 4 Open-market sale CEO sold 2,693 shares at an average $18.77 ($50,542)
- 4 Derivatives Options or other derivatives
- 4 Open-market sale CEO sold 700 shares at $35.07 ($24,548)
- 4 Open-market sale CEO sold 300 shares at $14.00 ($4,200)
- 4 Open-market sale CEO sold 10,879 shares at $14.00 ($152,306)
- 4 Exercise or conversion Director acquired 21,000 shares (option exercise)
- 4 Open-market sale CEO sold 6,386 shares at an average $14.07 ($89,838)
- 4 Open-market sale CEO sold 10,878 shares at $14.36 ($156,230)
Page 20 of 40 · 787 filings